Japan, Jan. 23 -- ELI LILLY & CO has got intellectual property rights for 'RXFP1 RECEPTOR AGONISTS.' Other related details are as follows:
Application Number: JP,2024-218625
Category (FI): A61P11/00,C07D495/08,C07D491/08,C07D498/08,C07D491/107,C07D491/048,C07D417/04,C07D495/10,C07D491/052,C07D277/68,C07D519/00,301,C07D487/08,C07D513/08,C07D513/04,301,C07D451/06,A61K31/439,A61K31/5386,A61K31/428,A61K31/553,A61K31/4355,A61K31/438,A61K31/444,A61K31/4995,A61K31/547,A61K31/46,A61P9/00,A61P9/04,A61P9/10,A61P13/12
Stage: Grant (IP right document published.)
Filing Date: Dec. 13, 2024
Publication Date: June 26, 2025
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
